5 Strong Buy Small Cap Stocks to Invest In
Small-cap stocks have seen a pullback after a strong first half of 2026, with the Russell 2000 down 11% from its August high. Earnings growth remains robust, with Russell 2000 EPS up 43% in Q2. Analysts highlight five small-cap stocks with strong buy ratings and significant upside potential, including National Energy Services Reunited Corp. (NESR), Applied Aerospace & Defense, Inc. (AADX), and Mineralys Therapeutics, Inc. (MLYS).
How this was made
The 30-second read
Why it matters
The recommendations aim to guide traders toward high‑upside small caps amid a broader market correction.
Market read
These picks could attract capital to the small‑cap space, potentially nudging the Russell 2000 higher if multiple stocks rally.
What to watch
Potential regulatory delays, concentration risk for NESR, and cash burn for MLYS could temper upside.
Background
The article lists five strong‑buy small‑cap stocks, providing recent financial metrics, analyst targets, and hedge‑fund holder counts.
Ticker impact
NESR reported Q2 revenue up 59% and net income tripled, with a $41.11 target price implying 100% upside.
likely upside as investors price in strong earnings and target price
Robust Q2 results and a high upside target drive bullish sentiment.
AADX disclosed Q2 net loss of $154 M and guidance for 2026 revenue $670‑$690 M, while analysts maintain a strong‑buy view with a $22.33 target.
possible upside if market focuses on long‑term guidance over short‑term loss
Guidance and analyst support may outweigh the quarterly loss.
MLYS highlighted FDA decision expected by Dec 22 for its lead drug and a $47.86 target price implying 133% upside.
upside pressure pending FDA decision
Market may price in the binary outcome of the FDA ruling.
Market effects
Highlights continued investor interest in small‑cap energy, defense, and biotech sectors.
U.S. small‑cap indices may see modest lift from highlighted picks.
Limited to U.S. investors focused on high‑growth small caps.
Counterpoint
Some investors may view the strong‑buy ratings as overly optimistic given the companies' size and execution risk.
Key entities
- companyNational Energy Services Reunited Corp.
Oilfield services firm with strong Q2 growth and a 100% upside target.
- companyApplied Aerospace & Defense, Inc.
Defense and space subsystem maker with guidance and strong‑buy rating.
- companyMineralys Therapeutics, Inc.
Pre‑revenue biotech awaiting FDA decision, with a 133% upside target.
